1. Home
  2. SY vs DCTH Comparison

SY vs DCTH Comparison

Compare SY & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SY
  • DCTH
  • Stock Information
  • Founded
  • SY 2013
  • DCTH 1988
  • Country
  • SY China
  • DCTH United States
  • Employees
  • SY N/A
  • DCTH N/A
  • Industry
  • SY EDP Services
  • DCTH Medical/Dental Instruments
  • Sector
  • SY Technology
  • DCTH Health Care
  • Exchange
  • SY Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • SY 384.4M
  • DCTH 388.3M
  • IPO Year
  • SY 2019
  • DCTH N/A
  • Fundamental
  • Price
  • SY $3.27
  • DCTH $12.27
  • Analyst Decision
  • SY Strong Buy
  • DCTH Strong Buy
  • Analyst Count
  • SY 1
  • DCTH 4
  • Target Price
  • SY $5.50
  • DCTH $24.50
  • AVG Volume (30 Days)
  • SY 829.2K
  • DCTH 727.1K
  • Earning Date
  • SY 11-19-2025
  • DCTH 11-07-2025
  • Dividend Yield
  • SY 0.80%
  • DCTH N/A
  • EPS Growth
  • SY N/A
  • DCTH N/A
  • EPS
  • SY N/A
  • DCTH 0.06
  • Revenue
  • SY $197,807,588.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • SY $8.61
  • DCTH $159.22
  • Revenue Next Year
  • SY $54.55
  • DCTH $42.78
  • P/E Ratio
  • SY N/A
  • DCTH $202.24
  • Revenue Growth
  • SY N/A
  • DCTH 491.35
  • 52 Week Low
  • SY $0.66
  • DCTH $8.77
  • 52 Week High
  • SY $6.28
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • SY 35.37
  • DCTH 64.88
  • Support Level
  • SY $3.33
  • DCTH $11.25
  • Resistance Level
  • SY $3.46
  • DCTH $12.05
  • Average True Range (ATR)
  • SY 0.21
  • DCTH 0.57
  • MACD
  • SY -0.06
  • DCTH 0.12
  • Stochastic Oscillator
  • SY 6.50
  • DCTH 81.03

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: